LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.79
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
0.79
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
LakeShore Biopharma Ltd Ratios and Metrics
Financials in CNY. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
PE Ratio | -7.22 | -10.53 | -12.94 | -33.48 | -21.08 | -202.52 | 1.27K | 364.15 | 87.57 | 230.70 | 694.25 | -145.47 | n/a | n/a |
PEG Ratio | -0.06 | 0.42 | -0.26 | 0.79 | -0.36 | 0.29 | -18.33 | -4.86 | 0.57 | 1.10 | -5.69 | n/a | n/a | n/a |
PS Ratio | 38.67 | 20.01 | 56.14 | 52.83 | 88.26 | 236.73 | 221.42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 8.96 | 7.11 | 9.76 | 14.09 | 12.86 | n/a | 30.93 | 13.22 | 13.29 | 15.84 | 16.18 | 15.42 | n/a | n/a |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.19K | -15.13K | -15.12K | -3.67K | 7.53K | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.19K | -15.13K | -15.12K | -3.67K | 7.53K | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.73 | 1.18 | 0.99 | 0.80 | 0.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.87 | 0.23 |
Quick Ratio | 0.87 | 0.72 | 1.09 | 1.26 | 1.29 | n/a | 0.46 | 1.61 | 5.89 | 7.20 | 11.76 | 2.77 | n/a | n/a |
Current Ratio | 1.13 | 0.94 | 1.41 | 1.54 | 1.57 | n/a | 0.46 | 1.61 | 5.89 | 7.20 | 11.76 | 2.77 | n/a | n/a |
Asset Turnover | 0.09 | 0.11 | 0.06 | 0.10 | 0.06 | n/a | 0.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -7.66 | -10.08 | -16.41 | -8.73 | n/a | n/a | -0.11 | -0.06 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.31 | -0.17 | -0.19 | -0.11 | -0.15 | n/a | 0.01 | 0.01 | 0.04 | 0.02 | 0.01 | -0.03 | n/a | n/a |
Return on Assets | -0.12 | -0.05 | -0.07 | -0.04 | -0.06 | n/a | 0.01 | 0.01 | 0.04 | 0.02 | 0.01 | -0.02 | n/a | n/a |
Return on Invested Capital | -0.16 | -0.07 | -0.12 | -0.07 | -0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.25 | 0.79 | 0.82 | 0.80 | 0.80 | 0.79 | 0.78 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -1.34 | -0.48 | -1.08 | -0.39 | -1.05 | -0.29 | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -1.44 | -0.52 | -1.09 | -0.4 | -1.05 | -0.49 | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.34 | -0.5 | -1.17 | -0.4 | -0.69 | -0.26 | -0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.61 | -0.43 | -1.02 | -0.35 | -0.52 | -0.22 | 0.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |